C
Carrie C. Lubitz
Researcher at Harvard University
Publications - 93
Citations - 2637
Carrie C. Lubitz is an academic researcher from Harvard University. The author has contributed to research in topics: Thyroid cancer & Thyroid. The author has an hindex of 25, co-authored 86 publications receiving 1916 citations. Previous affiliations of Carrie C. Lubitz include Cornell University & NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
Kepal N. Patel,Linwah Yip,Carrie C. Lubitz,Elizabeth G. Grubbs,Barbra S. Miller,Wen T. Shen,Peter Angelos,Herbert Chen,Gerard M. Doherty,Thomas J. Fahey,Electron Kebebew,Virginia A. LiVolsi,Nancy D. Perrier,Jennifer A. Sipos,Julie Ann Sosa,David L. Steward,Ralph P. Tufano,Christopher R. McHenry,Sally E. Carty +18 more
TL;DR: These clinical guidelines analyze the indications for thyroidectomy as well as its definitions, technique, morbidity, and outcomes and were created to assist clinicians in the optimal surgical management of thyroid disease.
Journal ArticleDOI
Annual financial impact of well-differentiated thyroid cancer care in the United States
Carrie C. Lubitz,Chung Yin Kong,Pamela M. McMahon,Gilbert H. Daniels,Yufei Chen,Konstantinos P. Economopoulos,G. Scott Gazelle,Milton C. Weinstein +7 more
TL;DR: Well‐differentiated thyroid cancer (WDTC) is a prevalent disease, which is increasing in incidence faster than any other cancer, and its costs are related to the diagnosis and treatment of newly diagnosed patients as well as the ongoing surveillance of patients who have a long life expectancy.
Journal ArticleDOI
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma
Raj K. Gopal,K Kübler,K Kübler,Sarah E. Calvo,Sarah E. Calvo,Sarah E. Calvo,Paz Polak,Dimitri Livitz,Daniel Rosebrock,Peter M. Sadow,Braidie Campbell,Samuel E. Donovan,Salma Amin,Benjamin J. Gigliotti,Zenon Grabarek,Zenon Grabarek,Zenon Grabarek,Julian M. Hess,Chip Stewart,Lior Z. Braunstein,Peter F. Arndt,Scott Mordecai,Angela R. Shih,Frances L Chaves,Tiannan Zhan,Carrie C. Lubitz,Jiwoong Kim,A. John Iafrate,Lori J. Wirth,Sareh Parangi,Ignaty Leshchiner,Gilbert H. Daniels,Vamsi K. Mootha,Dora Dias-Santagata,Gad Getz,David G. McFadden +35 more
TL;DR: In this paper, the authors performed whole-exome sequencing on a cohort of primary, recurrent, and metastatic tumors, and identified recurrent mutations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter.
Journal ArticleDOI
Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism.
Carrie C. Lubitz,George J. Hunter,Leena Hamberg,Sareh Parangi,Daniel Ruan,Atul A. Gawande,Randall D. Gaz,Gregory W. Randolph,Francis D. Moore,Richard A. Hodin,Antonia E. Stephen +10 more
TL;DR: 4D-CT identifies the more than half of abnormal parathyroids missed by traditional imaging and should be considered in cases with negative or discordant sestamibi and ultrasound, and bilateral exploration is warranted when multiple candidate lesions are reported on 4D- CT.
Journal ArticleDOI
Preoperative Localization Strategies for Primary Hyperparathyroidism: An Economic Analysis
TL;DR: Among commonly used strategies for preoperative localization of parathyroid pathology, US followed by selective 4D-CT is the least expensive.